Legal & Regulatory
BNY Mellon China JV gets regulator approval for exit of U.S. partner
A unit of Bank of New York Mellon Corp, one of the largest wealth managers in the United States, has won regulatory clearance for the sale of its stake in a joint venture with China's Western Securities Co Ltd , as a shake-out continues among partnerships in the country's financial industry.
Drugmakers may need indemnity for fast-tracked Ebola vaccines
Drugmakers are looking for some kind of indemnity from governments or multilateral agencies against possible losses or claims arising from the widespread emergency use of new Ebola vaccines in Africa.
Fed lays out scenarios for 2015 bank stress tests
The U.S. Federal Reserve said on Thursday it would assume wider corporate bond spreads and a higher oil price in the most strenuous scenario it will use in next year's run of its annual check of banks' health.
Abbott, Mylan silent on why changing tax-inversion terms
Drugmakers Abbott Laboratories (ABT.N) and Mylan Inc (MYL.O) on Wednesday declined to explain in detail why they changed the terms of a $5.3 billion deal in which Mylan will buy part of Abbott's overseas generics business and reincorporate for tax purposes in the Netherlands.




